M&A / Deals AI giant Anthropic buys Coefficient Bio for $400m PharmaphorumAnthropic has continued its push into the healthcare sector by acquiring New York start-up Coefficient Bio.M&A / DealsRead full story pharminent April 7, 2026 (Last updated: April 7, 2026) Pharmaphorum Anthropic has continued its push into the healthcare sector by acquiring New York start-up Coefficient Bio. M&A / DealsRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Amgen Seeks ‘Return to Growth’ for Tepezza as More Convenient Formulation Aces Phase 3Next: Sanofi immune drug hopeful posts mixed results in mid-stage tests Related Stories M&A / Deals J&J ventures further into in vivo CAR-T space with Sail partnership, potential buyout pharminent July 31, 2026 M&A / Deals Eisai and CORE Biomedicine agree on global licence for oncology pipeline pharminent July 29, 2026 M&A / Deals Argenx signs agreement to buy Forte Biosciences for $2.2bn pharminent July 28, 2026
